Research output: Contribution to journal › Article › peer-review
Activation of adenylyl cyclase by thienopyrimidine derivatives in rat testes and ovaries. / Shpakov, A.O.; Derkach, K.V.; Dar’in, D.V.; Lobanov, P.S.
In: Cell and Tissue Biology, No. 5, 2014, p. 400-406.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Activation of adenylyl cyclase by thienopyrimidine derivatives in rat testes and ovaries
AU - Shpakov, A.O.
AU - Derkach, K.V.
AU - Dar’in, D.V.
AU - Lobanov, P.S.
PY - 2014
Y1 - 2014
N2 - © 2014, Pleiades Publishing, Ltd. An important role in functioning of reproductive tissues is played by signaling systems that are regulated by luteinizing hormone (LH) and human chorionic gonadotropin (hCG) that include LH receptors as sensor components. Use of LH and hCG in medicine for treatment of diseases of the reproductive system and for solution of tasks of auxiliary reproductive technologies is restricted by their high cost, the necessity of parenteral introduction, and the presence of side effects. However, in the last few years, low molecular weight agonists of LH receptor have been developed that are devoid of these shortcomings and can be administered perorally. The most effective of them are thienopyrimidine derivatives, in particular the Org 43553 compound. The goal of this work was to study the effect of newly synthesized analogs of Org 43553, 5-amino-N-(tert-butyl)-4-(3-(isonicotinamide)phenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxamide (compound 1) and 5-amino-N-(tert-butyl)-2-(meth
AB - © 2014, Pleiades Publishing, Ltd. An important role in functioning of reproductive tissues is played by signaling systems that are regulated by luteinizing hormone (LH) and human chorionic gonadotropin (hCG) that include LH receptors as sensor components. Use of LH and hCG in medicine for treatment of diseases of the reproductive system and for solution of tasks of auxiliary reproductive technologies is restricted by their high cost, the necessity of parenteral introduction, and the presence of side effects. However, in the last few years, low molecular weight agonists of LH receptor have been developed that are devoid of these shortcomings and can be administered perorally. The most effective of them are thienopyrimidine derivatives, in particular the Org 43553 compound. The goal of this work was to study the effect of newly synthesized analogs of Org 43553, 5-amino-N-(tert-butyl)-4-(3-(isonicotinamide)phenyl)-2-(methylthio)thieno[2,3-d]pyrimidine-6-carboxamide (compound 1) and 5-amino-N-(tert-butyl)-2-(meth
U2 - 10.1134/S1990519X14050071
DO - 10.1134/S1990519X14050071
M3 - Article
SP - 400
EP - 406
JO - Cell and Tissue Biology
JF - Cell and Tissue Biology
SN - 1990-519X
IS - 5
ER -
ID: 7061385